한빛사논문 | BRIC

사경하 님의 논문 목록

고려대학교 의과대학

CV File 67 kb

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
- J. Immunother. Cancer, Mar 13 2024, 12 (3) e008638 | https://doi.org/10.1136/jitc-2023-008638
- 2024-03
- 생명과학
- 한빛사논문
Integrated proteogenomic characterization of glioblastoma evolution
- Cancer Cell, January 11, 2024 | https://doi.org/10.1016/j.ccell.2023.12.015
- 2024-01
- 생명과학
- 한빛사논문
Recapitulated Crosstalk between Cerebral Metastatic Lung Cancer Cells and Brain Perivascular Tumor Microenvironment in a Microfluidic Co-Culture Chip
- Adv. Sci., First published: 03 June 2022 | https://doi.org/10.1002/advs.202201785
- 2022-06
- 의약학
- 한빛사논문
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intratumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
- Genome Med., Published: 06 January 2022, 14, Article number: 1 | https://doi.org/10.1186/s13073-021-00995-8
- 2022-01
- 의약학
- 한빛사논문
Genomic landscape and clinical utility of Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program
- Cancer Discov., Published first December 3, 2021 | https://doi.org/10.1158/2159-8290.CD-21-1064
- 2021-12
- 의약학
- 한빛사논문
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
- Genome Med., Published: 25 January 2021, 13, Article number: 11 | https://doi.org/10.1186/s13073-021-00826-w
- 2021-01
- 의약학
- 한빛사논문
Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma
- Brain, Published: 22 January 2021, awaa408 | https://doi.org/10.1093/brain/awaa408
- 2021-01
- 의약학
- 한빛사논문
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
- Genome Biol., Published: 26 August 2020, 21, Article number: 216 (2020) | https://doi.org/10.1186/s13059-020-02140-x
- 2020-08
- 의약학
- 한빛사논문
A phase II trial of tipifarnib for patients with previously-treated, metastatic urothelial carcinoma harboring HRAS mutations
- Clin. Cancer Res., Published OnlineFirst July 7, 2020 | doi: 10.1158/1078-0432.CCR-20-1246
- 2020-07
- 의약학
- 한빛사논문
Comprehensive pharmacogenomic characterization of gastric cancer
- Genome Med., Published: 18 February 2020, 12, Article number: 17 | DOI : https://doi.org/10.1186/s13073-020-0717-8
- 2020-02
- 의약학
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기